Generic Name


Therapeutic Category



Atorvastatin 5 mg Tablet

Atorvastatin 10 mg Tablet

Atorvastatin 20 mg Tablet



     LIPLOW 5
    Each film coated tablet contains:
    Atorvastatin Calcium IP                       5mg

    Light Orange coloured, biconvex, film-coated tablet with smooth surface on both sides

    Each film coated tablet contains:
    Atorvastatin Calcium IP 

    Light orange coloured, round, biconvex, film coated tablet with 10 embossed on one side

    Each film coated tablet contains:
    Atorvastatin Calcium IP                       20mg

    Pink colored, round film coated tablet with breakline on one side


    Pharmacotherapeutic Group: Lipid lowering agents

    Pharmacodynamic properties:  Atorvastatin is a member of the drug class known as statins, used for lowering blood cholesterol.Atorvastatin competitively inhibits HMG-CoA reductase, the enzyme that catalyses the conversion of HMG-CoA to mevalonic acid. This results in the induction of the LDL receptors, leading to lowered LDL-cholesterol concentration.

    Pharmacokinetic properties: 

    AbsorptionRapid from the GI tract (oral); DistributionProtein-binding: 98%; MetabolismExtensively hepatic; converted to active inhibitors of HMG-CoA reductase; Excretion: Faeces (as metabolites); 14 hours (elimination half-life).

    INDICATIONS : Prevention of Cardiovascular Disease, Primary hypercholesterolemia, Elevated serum TG levels

     DOSE  :The recommended starting dose  is 10 or 20 mg once daily



    • May be taken with or without food

    Pregnancy Category: X

    Storage: Store below 25 °C

    Missed dose: Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

    CONTRAINDICATIONS Hypersensitivity

     SPECIAL PRECAUTIONS Patients who consume substantial quantities of alcohol. History of liver disease. Patients with risk factors for myopathy or rhabdomyolysis. Hypothyroidism should be properly managed prior to starting statin therapy. Children

    ADVERSE DRUG REACTIONS Headache, flatulence, diarrhoea, nausea, vomiting, anorexia, xerostomia, angioedema, myalgia, rash/pruritus, alopecia, allergy, infection, chest pain.Potentially Fatal: Thrombocytopenia. Rhabdomyolysis with acute renal failure.

    DRUG INTERACTIONS :  Increased AUC for norethindrone and ethinyl estradiol. Concomitant multiple doses of atorvastatin and digoxin increased steady-state digoxin levels. Increased risk of rhabdomyolysis when used concurently with fibrates. Co-admin with antacid suspensions and colestipol decreased atorvastatin levels.

    LIPLOW 5: Each box contains:
    10 strip pack of 10 tablets per strip
    LIPLOW 10: Each box contains:
    10 strip  pack of 10 tablets per strip
    LIPLOW 20: Each box contains:
    10 strip pack of 10 tablets per strip